Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of Vif for optimal infectivity: functional difference between Vif and Nef

被引:37
作者
Akari, H [1 ]
Uchiyama, T [1 ]
Fukumori, T [1 ]
Iida, S [1 ]
Koyama, AH [1 ]
Adachi, A [1 ]
机构
[1] Univ Tokushima, Sch Med, Dept Virol, Tokushima 7708503, Japan
关键词
D O I
10.1099/0022-1317-80-11-2945
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The functions of Vif and Nef in human immunodeficiency virus type 1 (HIV-1) infection have some similarities: Vif- and Nef-dependent enhancement of HIV-1 replication is cell type-specific, and defective mutations in these genes result in restricted proviral DNA synthesis in infected cells. It has recently been shown that pseudotyping HIV-1 by the envelope glycoprotein of vesicular stomatitis virus (VSV-G) targets HIV-1 entry to an endocytic pathway and suppresses the requirement of Nef for virus infectivity. In this study, we examined whether VSV-G pseudotyping suppresses the requirement of Vif for HIV-1 infectivity. It was found that pseudotyping HIV-1 by VSV-G did not compensate for the Vif function. Together with the findings that Vif does not influence virus binding/entry and virion incorporation of Env, it is concluded that Vif enhances HIV-1 infectivity at the post-entry step(s) independently of the Env function by a different mechanism to that of Nef.
引用
收藏
页码:2945 / 2949
页数:5
相关论文
共 40 条
  • [1] GENERATION AND CHARACTERIZATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANTS
    ADACHI, A
    ONO, N
    SAKAI, H
    OGAWA, K
    SHIBATA, R
    KIYOMASU, T
    MASUIKE, H
    UEDA, S
    [J]. ARCHIVES OF VIROLOGY, 1991, 117 (1-2) : 45 - 58
  • [2] PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE
    ADACHI, A
    GENDELMAN, HE
    KOENIG, S
    FOLKS, T
    WILLEY, R
    RABSON, A
    MARTIN, MA
    [J]. JOURNAL OF VIROLOGY, 1986, 59 (02) : 284 - 291
  • [3] Adachi Akio, 1996, P43
  • [5] NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS
    AIKEN, C
    TRONO, D
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (08) : 5048 - 5056
  • [6] BIOLOGICAL CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 MUTANTS IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    AKARI, H
    SAKURAGI, J
    TAKEBE, Y
    TOMONAGA, K
    KAWAMURA, M
    FUKASAWA, M
    MIURA, T
    SHINJO, T
    HAYAMI, M
    [J]. ARCHIVES OF VIROLOGY, 1992, 123 (1-2) : 157 - 167
  • [7] AKARI H, 1993, LAB INVEST, V69, P629
  • [8] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY
    BORMAN, AM
    QUILLENT, C
    CHARNEAU, P
    DAUGUET, C
    CLAVEL, F
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2058 - 2067
  • [9] vif-Negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus
    Chowdhury, IH
    Chao, W
    Potash, MJ
    Sova, P
    Gendelman, HE
    Volsky, DJ
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (08) : 5336 - 5345
  • [10] Direct interaction between the envelope and matrix proteins of HIV-1
    Cosson, P
    [J]. EMBO JOURNAL, 1996, 15 (21) : 5783 - 5788